Wakefield Resident Running the Boston Marathon in Support of JDRF

Patrick Glynn of Wakefield, MA will be running in the 120th Boston Marathon on April 18 in support of the New England Chapter of JDRF, the leading global organization focused on type 1 diabetes (T1D) research. This year marks Glynn's 5th year not only running the Marathon but running for a cause. Glynn is running on behalf of a close friend's daughter who was recently diagnosed with T1D.

"I am running on behalf of a young lady who has the heart of a lion! In a short period of time, Lilly and her family have embraced T1D and have become a very strong voice for JDRF and its mission. Lilly is the face of type 1 and she is living beyond type 1," stated Glynn.

The funds raised through the Boston Marathon will be directed by JDRF toward funding research to find a cure for T1D and its complications and to develop transformative treatments that enable people with T1D to live healthier, safer lives until that cure is found. In addition, the funds will support JDRF's local Outreach programs for individuals and families in eastern and central Massachusetts.

"Being part of the Boston Marathon has offered JDRF the opportunity to attract athletes with T1D and others with a personal connection to the disease to participate in the world's oldest annual marathon and one of the world's most prestigious road racing events," said Amy Montalto, Executive Director, JDRF New England Chapter.

To learn more about Patrick's efforts and to support him as he raises funds for JDRF through the Boston Marathon, visit https://www.crowdrise.com/patricksrunforlillyandjdrf.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow u on Twitter: @JDRF.